Paragen Bio logo — Advanced technology for halting autoimmune diseases's impact...

Paragen Bio

Advanced technology for halting autoimmune diseases's impact on healthy tissues and organs, empowering doctors to preserve and protect patient health

Founded 2018 Series Unknown Total: $6.00M Biopharma, Biotechnology +1

General Information

Company Name Paragen Bio
Founded Year 2018
Industries Biopharma, Biotechnology, Life Sciences
Funding Stage Series Unknown
Social

Get notified when Paragen Bio moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Paragen Bio

Paragen Bio is a biopharmaceutical startup with a mission to combat the impact of autoimmune diseases on healthy tissues and organs. Founded in 2018, the company has attracted notable attention from investors, securing a significant $6.00M in its last venture round investment on 14 August 2018. This round was backed by reputable investors such as AbbVie Ventures, OneVentures, and the Medical Research Commercialisation Fund (MRCF), showcasing the industry's confidence in Paragen Bio's advanced technology. The company's innovative solution offers a promising approach to managing autoimmune conditions by empowering physicians to prevent further deterioration and destruction of healthy tissues and organs. With a focus on biopharma, biotechnology, and life sciences, Paragen Bio is poised to make notable strides in the healthcare industry.

Taxonomy: autoimmune diseases, technology, immune system, tissue preservation, organ protection, medical innovation, disease management

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Venture Round •••••• 3
Investor Investor Investor
14 Aug 2018

Paragen Bio Alternatives & Competitors

Paragen Bio vs

Analyzing the potentials and effects of scientific and technical developments - comprehensively and...

12 employees
Education
Paragen Bio vs
TEKDesign
TEKDesign United States

Technology and Media Solutions and Services

5 employees
Paragen Bio vs

The leading voice and advocate for Middle Tennessee’s $8 billion technology ecosystem and 70,000 tec...

Grant
38 employees
Information Technology
Also compare with: Paragen Bio vs Murray Hill Group Murray Hill Group

FAQ About Paragen Bio

Advanced technology for halting autoimmune diseases's impact on healthy tissues and organs, empowering doctors to preserve and protect patient health
Paragen Bio was founded in 2018.
Paragen Bio operates in the following industries: Biopharma, Biotechnology, Life Sciences.
Paragen Bio has completed 1 funding round, raising a total of $6.00M. The latest funding stage is Series Unknown.
Top alternatives and competitors to Paragen Bio include Office of Technology Assessment at the German Bundestag (TAB), TEKDesign, Greater Nashville Technology Council, Telematica Inc., Murray Hill Group. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Paragen Bio and Office of Technology Assessment at the German Bundestag (TAB) are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Paragen Bio and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy